Stocks in play: Titan Medical Inc
Announced today that it has received payment from Medtronic plc after successfully achieving the final milestone under the development and license agreement announced on January 4, 2022. In addition, the senior secured loan from Medtronic has been retired. Titan Medical Inc shares T.TMD are trading down 0.01 cent at $0.73.
Read:
Double-Digit Growth in Global Cancer Immunotherapy Market to Drive Advancements Ahead of 2030
Wave of Massive ESG Investments Triggering Major Developments in Mining of Critical Minerals
Investment in New Plant-Based Alternative Meat Products Ramps Up Into 2022
New Treatments Needed as Breast Cancer Was Leading Killer of Female Cancer Patients in 2019
Biotech Sector Answering Calls for New Breast Cancer Treatment Developments in 2022